New Immune Effector Cellular Therapy Webinar: Bringing a Stand-Alone Immune Effector Cell Therapy Program into FACT Compliance
Register now:
Bringing a Stand-Alone Immune Effector Cell therapy Program into Compliance
In This Issue
- Just the FACTs, Volume 4
- FACT, ASTCT, CIBMTR, ISCT, and EBMT Publish Joint Statement Against Racism
- FACT Announces New Quality Management Series, Module 10: Validations
- FACT-CBA Webinar: The Effect of the COVID-19 Pandemic on Cord Blood Banking
- FACT Annual Compliance
- COVID-19 Update: FACT Accreditation
- New Immune Effector Cellular Therapy Webinar: Bringing a Stand-Alone Immune Effector Cell Therapy Program into FACT Compliance
- FACT Cord Blood Inspection and Accreditation Workshop at the 2020 Cord Blood Connect International Congress Officially Cancelled
- Update for HRSA-contracted Cord Blood Banks
- Heat-sealing label in cryopreservation bag pouch meets definition of “Affix”
- FACT Accreditation a Criterion for 2020-2021 Best Children’s Hospitals List
Accreditation Statistics
As of August 1, 2022
Cellular Therapy Entities
- Accredited: 250
- Applicants: 25
Cord Blood Banks
- Accredited: 56
- Applicants: 7
Congratulations to the following program for achieving initial FACT accreditation: King Abdulaziz Medical City - Riyadh, Saudi Arabia (adult and pediatric allogeneic and autologous hematopoietic progenitor cellular therapy; marrow and peripheral blood cellular therapy product collection; cellular therapy product processing with minimal manipulation). A complete list of accredited organizations can be found at www.factwebsite.org.
